Meril
Designing and delivering advanced medical devices to improve quality of life, as part of the Bilakhia Group.
| Date | Investors | Amount | Round |
|---|---|---|---|
* | $210m | Growth Equity VC | |
* | $200m Valuation: $6.6b | Growth Equity VC | |
| Total Funding | $410m | ||
| EUR | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|---|---|
| Revenues | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % growth | - | - | (35 %) | 164 % | (61 %) | - | - |
| EBITDA | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| Profit | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| % profit margin | - | 6 % | (14 %) | 9 % | (15 %) | - | - |
| EV | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
| EV / revenue | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| EV / EBITDA | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x | 00.0x |
| R&D budget | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 | 0000 |
Source: Company filings or news article
Related Content
Meril Life is a global medical device manufacturer headquartered in India, with a workforce of over 4000 employees. The company operates in more than 100 countries, including subsidiaries in the USA, Germany, Brazil, Russia, South Africa, Bangladesh, and Turkey. Meril Life specializes in the innovation, design, and development of state-of-the-art medical devices that are clinically relevant and technologically advanced. The company serves a diverse range of clients, including hospitals, clinics, and healthcare providers, offering products in vascular intervention, orthopedic implants, and diagnostic medical devices. Meril Life's business model focuses on the development and sale of high-quality medical devices, generating revenue through direct sales and partnerships with healthcare institutions. The company aims to improve patient outcomes and enhance the quality of life through its innovative solutions.
Keywords: medical devices, healthcare solutions, vascular intervention, orthopedic implants, diagnostic devices, global markets, innovation, technology, clinical relevance, patient outcomes.